nach oben

Somnologie

Erschienen in:

01.03.2010 | Originalien

Obstruktive Schlafapnoe bei Herzinsuffizienz

verfasst von: PD Dr. M. Arzt, R. Obermeier

Erschienen in: Somnologie | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die obstruktive Schlafapnoe (OSA) ist eine häufige Komorbidität der Herzinsuffizienz und trägt durch eine Erhöhung der Vor- und Nachlast sowie der Herzfrequenz bei Verminderung des Sauerstoffangebots zu deren Entstehung und Fortschreiten bei. „Continuous positive airway pressure“ (CPAP) ist die Therapie der Wahl und führt zu einer Verbesserung der linksventrikulären Funktion in dieser Patientengruppe. Die CPAP-Therapie sollte bei Patienten mit Herzinsuffizienz und OSA grundsätzlich in Erwägung gezogen, jedoch im Einzelfall hinsichtlich der erreichten kardiovaskulären Effekte, Unterdrückung der zentralen Atmungsereignisse und Änderung der Lebensqualität im Verlauf kritisch evaluiert werden. Die Frage, ob eine Indikation zur Behandlung der Schlafapnoe bei Patienten mit Herzinsuffizienz mit dem Ziel der Prognoseverbesserung gestellt werden kann, ist Gegenstand randomisierter Langzeitstudien.

Redfield MM, Jacobsen SJ, Burnett JC Jr et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 289:194–202CrossRefPubMed

Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933–989CrossRefPubMed

Levy D, Kenchaiah S, Larson MG et al (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:1397–1402CrossRefPubMed

Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018CrossRefPubMed

Kannel WB, Levy D, Cupples LA (1987) Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham study. J Cardiovasc Pharmacol 10(Suppl 6):S135–S140PubMed

McKee PA, Castelli WP, McNamara PM et al (1971) The natural history of congestive heart failure: The Framingham study. N Engl J Med 285:1441–1446PubMed

Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706–712CrossRefPubMed

Drager LF, Bortolotto LA, Lorenzi MC et al (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613–618CrossRefPubMed

Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365:1046–1053PubMed

10.

Shivalkar B, Van de Heyning C, Kerremans M et al (2006) Obstructive sleep apnea syndrome: More insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47:1433–1439CrossRefPubMed

11.

Usui K, Parker JD, Newton GE et al (2006) Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am J Respir Crit Care Med 173:1170–1175CrossRefPubMed

12.

Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82–93CrossRefPubMed

13.

Javaheri S, Parker TJ, Liming JD et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97:2154–2159PubMed

14.

Schulz R, Blau A, Borgel J et al (2007) Sleep apnoea in heart failure. Eur Respir J 29:1201–1205CrossRefPubMed

15.

Sin DD, Fitzgerald F, Parker JD et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101–1106PubMed

16.

Solin P, Bergin P, Richardson M et al (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574–1579PubMed

17.

Bixler EO, Vgontzas AN, Ten Have T et al (1998) Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144–148PubMed

18.

Shahar E, Whitney CW, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 163:19–25PubMed

19.

Malone S, Liu PP, Holloway R et al (1991) Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 338:1480–1484CrossRefPubMed

20.

Tolle FA, Judy WV, Yu PL et al (1983) Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55:1718–1724PubMed

21.

Somers VK, Dyken ME, Clary MP et al (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904CrossRefPubMed

22.

Tkacova R, Rankin F, Fitzgerald FS et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98:2269–2275PubMed

23.

Becker HF, Jerrentrup A, Ploch T et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73CrossRefPubMed

24.

Peppard PE, Young T, Palta M et al (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384CrossRefPubMed

25.

Pepperell JC, Maskell NA, Jones DR et al (2003) A randomized controlled trial of adaptive ventilation for cheyne-stokes breathing in heart failure. Am J Respir Crit Care Med 168:1109–1114CrossRefPubMed

26.

Suzuki M, Guilleminault C, Otsuka K et al (1996) Blood pressure „dipping“ and „non-dipping“ in obstructive sleep apnea syndrome patients. Sleep 19:382–387PubMed

27.

Verdecchia P, Porcellati C, Reboldi G et al (2001) Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 104:2039–2044CrossRefPubMed

28.

Verdecchia P, Schillaci G, Guerrieri M et al (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536PubMed

29.

Cintron G, Johnson G, Francis G et al (1993) Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87:VI17–VI23PubMed

30.

Mancini DM, Eisen H, Kussmaul W et al (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786PubMed

31.

Ponikowski P, Francis DP, Piepoli MF et al (2001) Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 103:967–972PubMed

32.

Arzt M, Harth M, Luchner A et al (2003) Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 107:1998–2003CrossRefPubMed

33.

Arzt M, Schulz M, Wensel R et al (2005) Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 127:794–802CrossRefPubMed

34.

Cahalin LP, Mathier MA, Semigran MJ et al (1996) The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110:325–332CrossRefPubMed

35.

Rostagno C, Olivo G, Comeglio M et al (2003) Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: Comparison with other methods of functional evaluation. Eur J Heart Fail 5:247–252CrossRefPubMed

36.

Kaneko Y, Floras JS, Usui K et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233–1241PubMedCrossRef

37.

Ruttanaumpawan P, Gilman MP, Usui K et al (2008) Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea. J Hypertens 26:1163–1168CrossRefPubMed

38.

Gilman MP, Floras JS, Usui K et al (2008) Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114:243–249

39.

Solin P, Kaye DM, Little PJ et al (2003) Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 123:1119–1126CrossRefPubMed

40.

Usui K, Bradley TD, Spaak J et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep anea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45:2008–2011CrossRefPubMed

41.

Ryan CM, Bradley TD (2005) Periodicity of obstructive sleep apnea in patients with and without heart failure. Chest 127:536–542CrossRefPubMed

42.

Tkacova R, Niroumand M, Lorenzi-Filho G et al (2001) Overnight shift from obstructive to central apneas in patients with heart failure: Role of pco2 and circulatory delay. Circulation 103:238–243PubMed

43.

Ferguson KA, Cartwright R, Rogers R et al (2006) Oral appliances for snoring and obstructive sleep apnea: A review. Sleep 29:244–262PubMed

44.

Gotsopoulos H, Kelly JJ, Cistulli PA (2004) Oral appliance therapy reduces blood pressure in obstructive sleep apnea: A randomized, controlled trial. Sleep 27:934–941PubMed

45.

Eskafi M, Cline C, Israelsson B et al (2004) A mandibular advancement device reduces sleep disordered breathing in patients with congestive heart failure. Swed Dent J 28:155–163PubMed

46.

Eskafi M (2004) Sleep apnoea in patients with stable congestive heart failure an intervention study with a mandibular advancement device. Swed Dent J Suppl 1–56

47.

Sin DD, Logan AG, Fitzgerald FS et al (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without cheyne-stokes respiration. Circulation 102:61–66PubMed

48.

Light RW, George RB (1983) Serial pulmonary function in patients with acute heart failure. Arch Intern Med 143:429–433CrossRefPubMed

49.

Hosenpud JD, Stibolt TA, Atwal K et al (1990) Abnormal pulmonary function specifically related to congestive heart failure: Comparison of patients before and after cardiac transplantation. Am J Med 88:493–496CrossRefPubMed

50.

Naum CC, Sciurba FC, Rogers RM (1992) Pulmonary function abnormalities in chronic severe cardiomyopathy preceding cardiac transplantation. Am Rev Respir Dis 145:1334–1338PubMed

51.

Naughton MT, Bookman I, Floras JS et al (1995) Effect of CPAP on respiratory mechanics in heart failure. Am J Respir Crit Care Med 151:A706

52.

Krachman SL, Crocetti J, Berger TJ et al (2003) Effects of nasal continuous positive airway pressure on oxygen body stores in patients with cheyne-stokes respiration and congestive heart failure. Chest 123:59–66CrossRefPubMed

53.

Barach AL, Swenson P (1939) Effect of breathing gases under positive pressure on lumens of small and medium sized bronchi. Arch Int Med 63:946–948

54.

Naughton MT, Rahman MA, Hara K et al (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91:1725–1731PubMed

55.

Kaye DM, Mansfield D, Aggarwal A et al (2001) Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 103:2336–2338PubMed

56.

Kaye DM, Mansfield D, Naughton MT (2004) Continuous positive airway pressure decreases myocardial oxygen consumption in heart failure. Clin Sci (Lond) 106:599–603

57.

De Hoyos A, Liu PP, Benard DC et al (1995) Haemodynamic effects of continuous positive airway pressure in humans with normal and impaired left ventricular function. Clin Sci (Lond) 88:173–178

58.

Ryan CM, Usui K, Floras JS et al (2005) Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 60:781–785CrossRefPubMed

59.

Mansfield DR, Gollogly NC, Kaye DM et al (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361–366CrossRefPubMed

60.

Smith LA, Vennelle M, Gardner RS et al (2007) Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: A randomized placebo-controlled trial. Eur Heart J 28:1221–1227CrossRefPubMed

61.

Wang H, Parker JD, Newton GE et al (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49:1625–1631CrossRefPubMed

62.

Kasai T, Narui K, Dohi T et al (2008) Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133:690–696CrossRefPubMed

63.

Arias MA, Garcia-Rio F, Alonso-Fernandez A et al (2005) Obstructive sleep apnea syndrome affects left ventricular diastolic function: Effects of nasal continuous positive airway pressure in men. Circulation 112:375–383CrossRefPubMed

64.

Arzt M, Young T, Finn L et al (2006) Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166:1716–1722CrossRefPubMed

65.

Hastings PC, Vazir A, O’Driscoll DM et al (2006) Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 27:748–755CrossRefPubMed

66.

Arzt M, Floras JS, Logan AG et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: A post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial (CANPAP). Circulation 115:3173–3180CrossRefPubMed

Titel: Obstruktive Schlafapnoe bei Herzinsuffizienz
verfasst von: PD Dr. M. Arzt
R. Obermeier
Publikationsdatum: 01.03.2010
Verlag: Springer-Verlag
Erschienen in: Somnologie / Ausgabe 1/2010
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI: https://doi.org/10.1007/s11818-010-0456-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Schlafgewohnheiten, Schlafprobleme und Verhaltensauffälligkeiten bei Schulkindern im Alter von 8–11 Jahren

Erhöhte Tagesschläfrigkeit in Österreich

Langzeiteffekte der Unterkieferprotrusionsschiene IST®

Bewältigungsstrategien beim Restless-legs-Syndrom

Zum Tode von Prof. Dr. med. Dr. rer. nat. Jörg Hermann Peter